Almost 50 000 Vials of IV Nitroglycerine Recalled

Shelley Wood


November 27, 2013

DEERFIELD, IL — Baxter International is voluntarily recalling approximately 49 000 vials (one lot) of its Nitroglycerine in 5% Dextrose injection after finding particulate matter in one vial[1].

The product was distributed in the US, Saudi Arabia, and Colombia between January 17 and October 10 of this year; there have been no adverse events associated with this issue, a Baxter spokesperson confirmed.

Particulate matter, however, could potentially lead to venous and/or arterial thromboembolism or an inflammatory reaction in the lungs or blood vessels.

According to the company's press release, the IV drug is indicated for the treatment of perioperative hypertension; control of congestive heart failure in the setting of acute MI; treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and beta-blockers; and induction of intraoperative hypotension.

Customers are being advised to look for lot number G105197 and if it is found to return it to Baxter for credit. The company can be contacted at 1-888-229-0001 between 7 am and 6 pm CT. Unaffected lots of product are available for replacement.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.